REFERENCES
- Alsalameh, S., Burian, M., Mahr, G., Woodcock, B. G., and Geisslinger, G., 2003. Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor, Aliment. Pharmacol. Ther 17 (2003), pp. 489–501, [INFOTRIEVE][CSA].
- Anonymous, 2003. New warnings for Bextra, FDA Consum 37 (2003), p. 5, [CSA].
- Fenton, C., Keating, G. M., and Wagstaff, A. J., 2004. Valdecoxib: A review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain, Drugs 64 (2004), pp. 1231–1261, [INFOTRIEVE][CSA][CROSSREF].
- Gotta, A. W., 2002. Valdecoxib (Pharmacia), Curr. Opin. Invest. Drugs 3 (2002), pp. 240–245, [CSA].
- Seifert, S. A., Jacobitz, K., Ling, L., Bangh, S., Bronstein, A. C., and Lansinger, P. A., 2004. Valdecoxib (Bextra(R)) overdose: A case series, J. Toxicol. Clin. Toxicol 42 (2004), p. 723, [CSA].